10:00 – 10:10

Welcome Address

Eileen Regan

VP, Life Science Applications 

Indica Labs 

10:10 – 10:30

What’s New in HALO AP v2.4 

Hallie Rane

Associate Product Manager, Clinical

Indica Labs

Abstract

HALO AP® is a digital pathology platform built for flexible clinical workflows, with seamless options for integrating data into research pipelines. HALO AP® v2.4 introduces a deep archive module for cost-efficient long-term storage, streamlined anonymization for exporting clinical cases for research use, and secure external consultant access for cross-institution collaboration. With added real-time conferencing and expanded DICOM and LIS integration capabilities, v2.4 strengthens the connection between clinical environments and research while ensuring scalability and security.

Biography

Hallie Rane received a BS in biology from the University of New Mexico and has a background in molecular biology and evolution. Hallie joined Indica Labs in 2023 as the Product Specialist for HALO AP®. Prior to Indica Labs, Hallie worked in both industry and academic positions and has held a variety of technical and customer-facing roles, where she collaborated with customers, scientists, and technicians to develop a diverse array of products. Her journey encompassed ventures into biotechnology innovation, academic research labs, and even the realm of craft beer production, where she served as Head Brewer.

10:30 - 10:55

Beyond the Basics: Customizing HALO Link Deployments 

Kat Latimer, ME Biomedical Engineering

HALO Link Associate Product Manager

Indica Labs

Abstract 

HALO Link is an enterprise image management solution (IMS) built to adapt to the unique needs of research organizations. This presentation will showcase how a deployment can be tailored to streamline collaboration, strengthen compliance, and connect seamlessly with the tools you rely on. With flexible study organization, custom metadata, and integrations with HALO, HALO AI, Visiopharm, and LIS/LIMS systems, HALO Link supports a wide range of workflows. We’ll also explore how advanced features like system-wide auditing, database consolidation, and API-driven integrations empower institutions to scale with confidence. Join us to learn how HALO Link delivers a future-ready IMS designed to accelerate research, simplify operations, and evolve alongside your organization’s goals.

Biography

Kat Latimer earned a ME in Biomedical Engineering from Colorado State University in 2025 and BS in Biochemistry from the University of New Mexico in 2018. Her graduate studies focused on tissue engineering and the use of biomaterials for wound healing. During her undergraduate studies, Kat participated in several research opportunities including investigating the role of cellular adhesion proteins in HPV oncogene expression.  In 2020 she joined Indica Labs as a Software Quality Assurance Analyst. In 2021 she transitioned to the Product Management team and has since been promoted to the HALO Link Associate Product Manager role where she works closely with the software developers creating new features to improve the user experience. 

10:55 - 11:05

Break

11:05 - 11:35

Leveraging HALO AI for Digital Pathology: From Preclinical Drug Discovery to Translational Medicine 

Jas Singh, Pharm D, PhD

Associate Director

Arcus Biosciences

Abstract 

This presentation will present case studies demonstrating the application of HALO and HALO-AI in analyzing preclinical and retrospective clinical samples to support mechanism-of-action (MOA) studies. The discussion will emphasize the role of AI-driven image analysis in enabling robust data-informed decision-making, minimizing variability, and expediting translational research to advance drug development.

Biography

Jaskirat Singh, Ph.D., is a translational scientist with more than 15 years of experience in pharmaceutical research and development. His expertise lies in the identification and development of tissue-based biomarkers that enable the stratification of patient populations for precision medicine. He currently holds the position of Associate Director at Arcus Biosciences, where he leads a team of scientists in the development and implementation of singleplex and multiplex immunohistochemistry (IHC) assays to support both preclinical and clinical programs for biomarker discovery. Dr. Singh earned his Ph.D. from the Mount Sinai School of Medicine and subsequently completed his postdoctoral training at Genentech.

11:35 - 12:05

Revealing Cellular Diversity with HALO® High Dimensional Analysis

Maciej Zerkowski

Manager, Life Science Applications

Indica Labs

Abstract 

As multiplex imaging expands the number of biomarkers captured per sample, analysis methods must keep pace. Traditional thresholding approaches quickly become impractical when tens of markers yield thousands of possible phenotypes.

The HALO® High Dimensional Analysis module provides an integrated solution, combining dimensionality reduction (UMAP) and unsupervised clustering (K-means, Phenograph) within the familiar HALO environment. This allows users to detect emergent phenotypes, explore relationships between cell populations, and validate findings directly against spatial context in the original images.

In this session, we will cover:

 • The analytical challenges posed by highly multiplexed imaging

 • How clustering and dimensionality reduction workflows are implemented in HALO

 • Examples of linking results back to images for biological validation and quality control

Biography

Maciej manages the North American field applications team in the US and Canada, which provides applications and sales support for Indica Labs’ customers. He has earned a Bachelor of Science degree in Molecular and Cell Biology at the University of Connecticut, whereupon he began his professional career as a Research Assistant at Yale University, working on a then novel fluorescence-based automated quantitative image analysis (AQUA) technology. He subsequently joined HistoRx, a start-up founded to commercialize the AQUA platform, where he had the opportunity to help guide its development from a temperamental academic project into a robust and successful commercial product. Following the sale of HistoRx, he began work as a Field Application Scientist at Cambridge Research and Instrumentation, a biotechnology startup focused on multispectral imaging and analysis of tissue samples, which was eventually acquired by PerkinElmer, a global life sciences corporation. Prior to joining Indica Labs in 2022, Maciej was the lead Field Applications Scientist at Ionpath, where he worked with Ionpath’s proprietary Multiplexed Ion Beam Imaging (MIBI) technology, a mass spectrometry imaging device enabling the simultaneous quantitation of up to 40 antibody markers on tissue sections.

12:05 - 12:20

Unlocking Multi-Modal Imaging for Advanced Research with Aperio FL Scanning Systems

Timothy Murphy-Stevens, PhD

Solutions Architect-Pathology Imaging

Leica Biosystems

Abstract 

TBA

Biography

Timothy Murphy-Stevens, PhD is a seasoned biomedical research applications and technical support professional with more than 20 years of experience at the intersection of science and technology. A lifelong science enthusiast, he was captivated early on by the power of microscopy—turning the invisible visible—and has since dedicated his career to helping researchers harness cutting-edge imaging tools to push the boundaries of discovery.

With deep expertise in light microscopy techniques, including bright-field, dark-field, phase contrast, DIC, fluorescence, live cell imaging, and confocal microscopy, Tim has built a 20+ year track record in consulting, training, and supporting advanced imaging systems and analysis software. His work spans diverse fields, including biological research, clinical pathology, and material sciences. 

Known for his ability to bridge science and technology, Tim excels in application support, product management, marketing, and the complete business cycle, from technical training to successful sales. He is also a skilled educator, delivering impactful seminars, product training, and hands-on instruction to both customers and sales teams.

Timothy is most proud of having publications on snail brains to whale brains!

12:20 - 1:00

Lunch

1:00 –1:25

Pharma Services AI-Driven Workflows: GCP, ADC, and Automated AI Training

Stephanie Jerman, PhD

Senior Imaging Scientist

Indica Labs

Abstract 

Our Pharma Services team is an experienced multidisciplinary team that develops AI-powered image analysis workflows to support your preclinical and clinical studies. Developing a strategy that involves a combination of in-house resources and outsourcing allows customers to focus on the key scientific questions to drive their biomarker studies forward. This presentation will provide a brief introduction of the group, introduce new capabilities, and highlight two AI workflows: analysis of antibody drug conjugate (ADC) target expression and bystander effect, and workflows for moving towards more of an automated process for AI training using ground-truth annotations from same-section mIF or IHC panels.

Biography

Stephanie Jerman earned a PhD in Biomedical Sciences in the Pathology Department at the University of New Mexico. She then completed her postdoctoral training in the Genetics department at Yale University and an Immuno-oncology lab at the University of New Mexico. Her research focused on genetic disease mechanisms from early embryotic development through adulthood as well as cancer immunology. Throughout her graduate and postdoctoral studies, she developed expertise in many assays such as IHC, mIF, ISH/FISH, and digital image analysis. Stephanie joined the Indica Labs Pharma Services team in 2018 and is now a Senior Imaging Scientist with extensive experience using all HALO modules, HALO AI, and HALO Link to complete various projects ranging from preclinical, translational, and clinical studies. She is also GCP certified to ensure practices are met to produce reliable and credible data for all clinical trial studies. Stephanie works with research institutions worldwide to develop tailored image analysis solutions designed to support customers’ research needs.

1:25 – 1:55

Cost Optimization of an AWS Environment in Neurodegenerative Disease Research

Mark James Montine

Sr. Computer Specialist

University of Washington 

Abstract 

Part of our core duties at the University of Washington BioRepository and Integrated Neuropathology Lab is to be a brain bank and tissue repository for researchers around the world.  In addition to tissue, we also store hundreds of thousands of images ranging from 3D images of entire brains all the way down to sub-cellular imaging.  Back in 2023, our slide image storage, specifically, was getting out of control.  

I have worked closely with Cloud Services over the last two years to overhaul, streamline, and optimize our Amazon Web Services environment.  We have managed to significantly reduce costs while rapidly growing a system that encompasses dozens of researchers, hundreds of collaborators, thousands of cases, and tens of thousands of slides.

Biography

Mark Montine is the Senior Computer Specialist for the Keene Lab at the University of Washington in Seattle.  His main responsibilities revolve around developing, implementing, and improving systems and operations related to tissue imaging, tissue inventorying, image storage, and image sharing. 

1:55 - 2:05

Coffee break and Networking

2:05 – 2:35

The Tissue Tells: Exploratory Trials in Translational Pathology

Carmen Ballesteros-Merino, PhD

Senior Principal Scientist

Bristol Myers Squibb

Abstract

TBA

Biography

TBA

2:35 - 3:05

New Features and Upcoming Developments in Life Science Products at Indica Labs

Noemi Kedei, MD

Director of Product, Life Sciences

Indica Labs

Abstract

 The digital pathology landscape continues to evolve and improve and the software solutions from Indica Labs are no exception. This presentation will showcase the latest advancements in the HALO, HALO AI, and HALO Link products and provide insight into future directions. Users will learn how the enhancements accelerate AI-powered analysis, streamline workflows, and unlock deeper discovery from complex imaging data. Get a first look at the latest product updates and learn more about focus areas of development for 2025!

Biography

Noemi Kedei earned an MD degree from University Medical School of Debrecen, Hungary. She did her postdoctoral training and worked later as staff scientist in the Laboratory of Cancer Biology and Genetics, NCI. Her research focused on identifying mechanisms involved in the differential effect of natural compounds and their engineered derivatives acting on protein kinase Cs (PKCs), validated targets for anti-cancer treatment. In 2018 she joined the Collaborative Protein Technology Resources (OSTR, CCR, NCI) core facility to implement a variety of spatial protein and transcriptomics technologies and lead related operations as services to NCI investigators. Noemi provided the expertise for development of project based customized antibody protein panels for detection of 40-60 protein targets at single cell level in tissue sections using the CODEX/Phenocycler fusion technology, and ensured optimal end efficient instrument use. In addition, she advised and supported users on image analysis tools for quantitative image analysis combining different AI-enabled HALO modules and NCI developed pipelines for downstream analysis. Noemi joined Indica Labs as Director of Product - Life Sciences in May, 2025.

3:05 – 3:10

Closing Remarks

Eileen Regan

VP, Life Science Applications

Indica Labs

3:10 - 3:30

Live Demos

Indica Staff